Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC medical records management for services performed within their practices as those practices that utilize an outside supplier for the TCs or PCs of their tests. Response: We are unclear as to what the commenter is suggesting. We did not propose to, and this final rule does not, impose tighter billing restrictions on TCs and PCs ordered by dermatologic surgeons than for other specialties, and does not impose tighter billing restrictions for dermatologic surgeons who perform TCs and PCs than it does for those physician practices that purchase TCs and PCs from an outside supplier. We note that the commenter did not provide an explanation of why patient access to care in rural or underserved areas would be affected by our proposed revisions. Comment: A letter writing campaign expressed concern regarding the proposals to the anti-markup provisions, contending that it would limit the ability of allergists to provide services on a part-time basis with more than one group and, in particular, would limit access to allergy care (including allergy diagnostic tests), to Medicare beneficiaries in rural or underserved areas. The commenters urged that our proposals not be implemented. Response: We have adopted the first proposed alternative with modification, whereby the anti-markup 518
CMS-1403-FC provisions will not apply to TCs and PCs supervised or performed by a physician who performs “substantially all” (at least 75 percent) of his or her professional services for the billing physician or other supplier, which provides some flexibility for the performing physician to work for more than one billing physician or other supplier. Moreover, this final rule provides additional flexibility by allowing arrangements that do not come within the protection of the “substantially all” test to avoid the application of the anti-markup payment limitation by complying on a case-by-case basis with the existing site- of-service approach (as clarified by this final rule with comment period). We believe that this addresses the commenters’ concerns. 519
- Page 467 and 468: CMS-1403-FC Response: With respect
- Page 469 and 470: CMS-1403-FC to focus on the medical
- Page 471 and 472: CMS-1403-FC service” approach bec
- Page 473 and 474: CMS-1403-FC have the right to recei
- Page 475 and 476: CMS-1403-FC 2 approach finalized he
- Page 477 and 478: CMS-1403-FC the ordering physician
- Page 479 and 480: CMS-1403-FC ensure an adequate nexu
- Page 481 and 482: CMS-1403-FC entity” should be def
- Page 483 and 484: CMS-1403-FC between the performing
- Page 485 and 486: CMS-1403-FC supplier” to encompas
- Page 487 and 488: CMS-1403-FC to continue to provide
- Page 489 and 490: CMS-1403-FC requirements of the Alt
- Page 491 and 492: CMS-1403-FC supervised in the offic
- Page 493 and 494: CMS-1403-FC reducing access to care
- Page 495 and 496: CMS-1403-FC commenter supported ado
- Page 497 and 498: CMS-1403-FC “outside supplier,”
- Page 499 and 500: CMS-1403-FC group could recover onl
- Page 501 and 502: CMS-1403-FC incurred, thereby compe
- Page 503 and 504: CMS-1403-FC needed to provide the t
- Page 505 and 506: CMS-1403-FC performing supplier for
- Page 507 and 508: CMS-1403-FC providers, the services
- Page 509 and 510: CMS-1403-FC commenter also expresse
- Page 511 and 512: CMS-1403-FC overutilization of in-o
- Page 513 and 514: CMS-1403-FC provisions for single-s
- Page 515 and 516: CMS-1403-FC we did not propose such
- Page 517: CMS-1403-FC and PCs supervised or p
- Page 521 and 522: CMS-1403-FC (Pub. L. 110-173) (MMSE
- Page 523 and 524: CMS-1403-FC reporting data on quali
- Page 525 and 526: CMS-1403-FC PQRI and a more detaile
- Page 527 and 528: CMS-1403-FC and our responses to th
- Page 529 and 530: CMS-1403-FC provisions of the Priva
- Page 531 and 532: CMS-1403-FC reducing eligible profe
- Page 533 and 534: CMS-1403-FC administrative or judic
- Page 535 and 536: CMS-1403-FC professionals who did n
- Page 537 and 538: CMS-1403-FC base the incentive paym
- Page 539 and 540: CMS-1403-FC A few commenters noted
- Page 541 and 542: CMS-1403-FC administrative burden t
- Page 543 and 544: CMS-1403-FC requested that more det
- Page 545 and 546: CMS-1403-FC incentive payments for
- Page 547 and 548: CMS-1403-FC December 31, 2009 and J
- Page 549 and 550: CMS-1403-FC the reporting period fo
- Page 551 and 552: CMS-1403-FC proposed to carry forwa
- Page 553 and 554: CMS-1403-FC measures group is appli
- Page 555 and 556: CMS-1403-FC measures results and nu
- Page 557 and 558: CMS-1403-FC (Delmarva Foundation fo
- Page 559 and 560: CMS-1403-FC registries to report on
- Page 561 and 562: CMS-1403-FC reporting options for r
- Page 563 and 564: CMS-1403-FC incentive payment for P
- Page 565 and 566: CMS-1403-FC to report 2009 PQRI qua
- Page 567 and 568: CMS-1403-FC Comment: We received nu
<strong>CMS</strong>-1403-FC<br />
medical records management for services performed within<br />
their practices as those practices that utilize an outside<br />
supplier for the TCs or PCs of their tests.<br />
Response: We are unclear as to what the commenter is<br />
suggesting. We did not propose to, and this final rule<br />
does not, impose tighter billing restrictions on TCs and<br />
PCs ordered by dermatologic surgeons than for other<br />
specialties, and does not impose tighter billing<br />
restrictions for dermatologic surgeons who perform TCs and<br />
PCs than it does for those physician practices that<br />
purc<strong>has</strong>e TCs and PCs from an outside supplier. We note<br />
that the commenter did not provide an explanation of why<br />
patient access to care in rural or underserved areas would<br />
be affected by our proposed revisions.<br />
Comment: A letter writing campaign expressed concern<br />
regarding the proposals to the anti-markup provisions,<br />
contending that it would limit the ability of allergists to<br />
provide services on a part-time basis with more than one<br />
group and, in particular, would limit access to allergy<br />
care (including allergy diagnostic tests), to Medicare<br />
beneficiaries in rural or underserved areas. The<br />
commenters urged that our proposals not be implemented.<br />
Response: We have adopted the first proposed<br />
alternative with modification, whereby the anti-markup<br />
518